Clinical Trial Update: Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function [Phase 2]

View source ↗

Summary

This Phase 2 pilot study evaluated the effect of ivacaftor on lung function in subjects with cystic fibrosis who have residual CFTR function; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ivacaftor (ivacaftor)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2015-05-19